Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 2, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 124
- Market value to sell
- $154.0M
- Sellers
- 24
- Companies
- 13
- Under 10b5-1 plans
- 80
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | Jan 5, 202611:07 AM ET | Gibson ChristopherDirector | 40.0K | $170.0K | Jan 5, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Jan 2, 20264:29 PM ET | Nikki StetzOfficer | 40.0K | $777.2K | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Jan 2, 20264:28 PM ET | Sona Trust U/A DTD 05/09/2025Officer | 80.0K | $1.55M | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Jan 2, 20264:28 PM ET | Oan Trust U/A DTD 05/09/2025Officer | 100.0K | $1.94M | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Dec 29, 20259:41 AM ET | Taylor Ben ROfficer | 21.4K | $89.4K | Dec 29, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Dec 22, 202512:20 PM ET | Najat KhanOfficer | 124.4K | $548.6K | Dec 22, 202510b5-1 | Merrill Lynch | SEC |
| BMNPBitmine Immersion Technologies, Inc. | Dec 19, 202511:57 AM ET | Bates Jonathan RobertFormer CEO | 96.8K | $2.89M | Dec 19, 2025 | UBS Securities LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Dec 19, 20259:52 AM ET | Gibson ChristopherOfficer · Director | 40.0K | $180.0K | Dec 19, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| BMNPBitmine Immersion Technologies, Inc. | Dec 12, 20253:30 PM ETAmended | Bates Jonathan RobertFORMER CEO | 152.0K | $5.43M | Dec 12, 2025 | UBS Securities LLC | SEC |
| NXDTNexpoint Diversified Real Estate Trust | Dec 11, 20259:24 PM ET | Mitts, BrianDirector | 14.1K | $42.2K | Dec 12, 2025 | Charles Schwab & Co. Inc. | SEC |
| BMNPBitmine Immersion Technologies, Inc. | Dec 10, 20253:57 PM ET | Seth A BaylesOfficer | 1.50K | $149.1K | Dec 10, 2025 | UBS Financial Services Inc | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Dec 4, 202510:01 AM ET | Gibson ChristopherOfficer · Director | 40.0K | $185.2K | Dec 4, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Dec 2, 202512:15 PM ET | Borgeson BlakeDirector | 220.0K | $961.4K | Dec 2, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Dec 1, 202512:20 PM ET | Einar RoosilehtOfficer | 70.0K | $1.27M | Dec 1, 202510b5-1 | MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Nov 19, 202510:17 AM ET | Gibson ChristopherOfficer · Director | 40.0K | $166.4K | Nov 19, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| SMHISEACOR Marine Holdings Inc. | Nov 12, 20254:05 PM ET | Julie PersilyDirector | 7.00K | $51.8K | Nov 11, 2025 | Merrill Lynch | SEC |
| RSIRush Street Interactive, Inc. | Nov 10, 20254:33 PM ET | Richard T SchwartzDirector · Officer | 387.8K | $6.69M | Nov 10, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| BMNPBitmine Immersion Technologies, Inc. | Nov 6, 20252:52 PM ET | Jeffrey Van OsNone | 18.4K | $700.0K | Nov 6, 2025 | Kingswood US | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Nov 4, 20259:51 AM ET | Gibson ChristopherOfficer · Director | 40.0K | $208.4K | Nov 4, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Nov 3, 20254:28 PM ET | Mattias StetzOfficer | 60.0K | $1.02M | Nov 3, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | Nov 3, 202512:31 PM ET | Einar RoosilehtOfficer | 70.0K | $1.19M | Nov 3, 202510b5-1 | MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Oct 23, 202510:37 AM ET | Gibson ChristopherOfficer · Director | 100.0K | $570.0K | Oct 23, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | Oct 10, 202510:24 AM ET | Gibson ChristopherOfficer · Director | 100.0K | $604.0K | Oct 10, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | Oct 8, 20254:36 PM ET | Richard SchwartzOfficer · Director | 193.9K | $3.53M | Oct 8, 202510b5-1 | Merrill Lynch, Pierce, Fenner & Smith Inc. | SEC |